Skip to main content
SpringerLink
Log in

Routine CMV vaccination cost effective in France

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 euros

Reference

  • N'Diaye DS, et al. Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France. Vaccine : 31 Jan 2018. Available from: URL: http://doi.org/10.1016/j.vaccine.2018.01.042

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Routine CMV vaccination cost effective in France. PharmacoEcon Outcomes News 797, 28 (2018). https://doi.org/10.1007/s40274-018-4737-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4737-1

Search

Navigation